AANAT, aralkylamine N-acetyltransferase, 15

N. diseases: 36; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0393770
Disease: Delayed Sleep Phase Syndrome
Delayed Sleep Phase Syndrome
0.310 Biomarker disease CTD_human The data suggest that AA-NAT could be a susceptibility gene for DSPS. 12736803 2003
CUI: C0393770
Disease: Delayed Sleep Phase Syndrome
Delayed Sleep Phase Syndrome
0.310 Biomarker disease BEFREE The data suggest that AA-NAT could be a susceptibility gene for DSPS. 12736803 2003
CUI: C0005587
Disease: Depression, Bipolar
Depression, Bipolar
0.300 Biomarker disease PSYGENET We assessed the contribution of AANAT gene variability to susceptibility to MD considering common and rare genetic variations through a sequential sequencing and single nucleotide polymorphism (SNP)-based genotyping approach in a sample of 445 unrelated patients with MD (257 unipolar MD, 188 bipolar depression) and 440 community-based screened control subjects. 20459461 2010
Nonorganic Sleep Wake Cycle Disorders
0.300 Biomarker disease CTD_human Significant association of the arylalkylamine N-acetyltransferase ( AA-NAT) gene with delayed sleep phase syndrome. 12736803 2003
CUI: C0751758
Disease: Advanced Sleep Phase Syndrome
Advanced Sleep Phase Syndrome
0.300 Biomarker disease CTD_human Significant association of the arylalkylamine N-acetyltransferase ( AA-NAT) gene with delayed sleep phase syndrome. 12736803 2003
CUI: C0751759
Disease: Non-24 Hour Sleep-Wake Disorder
Non-24 Hour Sleep-Wake Disorder
0.300 Biomarker disease CTD_human Significant association of the arylalkylamine N-acetyltransferase ( AA-NAT) gene with delayed sleep phase syndrome. 12736803 2003
CUI: C0751760
Disease: Shift-Work Sleep Disorder
Shift-Work Sleep Disorder
0.300 Biomarker disease CTD_human Significant association of the arylalkylamine N-acetyltransferase ( AA-NAT) gene with delayed sleep phase syndrome. 12736803 2003
CUI: C0877792
Disease: Sleep Disorders, Circadian Rhythm
Sleep Disorders, Circadian Rhythm
0.300 Biomarker group CTD_human Significant association of the arylalkylamine N-acetyltransferase ( AA-NAT) gene with delayed sleep phase syndrome. 12736803 2003
CUI: C0011570
Disease: Mental Depression
Mental Depression
0.300 Biomarker disease PSYGENET The mutant, AANAT knocked down C57BL/6J mice displayed significantly longer times of immobility ("depression"). 11316327 2001
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.300 Biomarker disease PSYGENET The mutant, AANAT knocked down C57BL/6J mice displayed significantly longer times of immobility ("depression"). 11316327 2001
CUI: C0011853
Disease: Diabetes Mellitus, Experimental
Diabetes Mellitus, Experimental
0.200 Biomarker disease RGD Increased melatonin synthesis in pineal glands of rats in streptozotocin induced type 1 diabetes. 18624957 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.200 Biomarker disease RGD Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. 16441550 2006
Finding of Mean Corpuscular Hemoglobin
0.100 GeneticVariation phenotype GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
CUI: C0021704
Disease: Intelligence
Intelligence
0.100 GeneticVariation phenotype GWASCAT Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. 29844566 2018
CUI: C0206161
Disease: Reticulocyte count (procedure)
Reticulocyte count (procedure)
0.100 GeneticVariation phenotype GWASCAT The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. 27863252 2016
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.030 GeneticVariation disease BEFREE For combined heterozygotes and rare homozygotes a slightly elevated breast cancer risk was found for rs8150 in gene AANAT (OR 1.17; 95% CI 1.01-1.36), and a reduced risk for rs3816358 in gene ARNTL (OR 0.82; 95% CI 0.69-0.97) in the complete study population. 25229211 2014
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.030 GeneticVariation disease BEFREE For combined heterozygotes and rare homozygotes a slightly elevated breast cancer risk was found for rs8150 in gene AANAT (OR 1.17; 95% CI 1.01-1.36), and a reduced risk for rs3816358 in gene ARNTL (OR 0.82; 95% CI 0.69-0.97) in the complete study population. 25229211 2014
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.030 GeneticVariation disease BEFREE In the main effects analysis, CC carriers of rs4238989 and GG carriers of rs3760138 in the AANAT gene had increased risk of breast cancer, whereas TT carriers of BMAL1 rs2278749 and TT carriers of CLOCK rs3749474 had reduced risk. 23822714 2013
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.030 GeneticVariation disease BEFREE In the main effects analysis, CC carriers of rs4238989 and GG carriers of rs3760138 in the AANAT gene had increased risk of breast cancer, whereas TT carriers of BMAL1 rs2278749 and TT carriers of CLOCK rs3749474 had reduced risk. 23822714 2013
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.030 GeneticVariation disease BEFREE No significant breast cancer associations were found for variants in the AANAT gene. 22138747 2012
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.030 GeneticVariation disease BEFREE No significant breast cancer associations were found for variants in the AANAT gene. 22138747 2012
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.020 Biomarker disease BEFREE AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors. 28604612 2017
CUI: C1510586
Disease: Autism Spectrum Disorders
Autism Spectrum Disorders
0.020 Biomarker disease BEFREE Our results elucidate the enzymatic mechanism for melatonin deficit in ASD, involving a reduction of both enzyme activities contributing to melatonin synthesis (AANAT and ASMT), observed in the pineal gland as well as in gut and platelets of patients. 28522826 2017
Malignant neoplasm of colon and/or rectum
0.020 Biomarker disease BEFREE AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors. 28604612 2017
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.020 AlteredExpression disease BEFREE Finally, a significant correlation was observed between AA-NAT and edn-1 expression downregulation in human colorectal cancer tissues. 24628039 2014